Hitomi Sumiyoshi Okuma (Hitomi Sumiyoshi-Okuma, Hitomi S Okuma)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 14

Top Topics

Acute Lymphoblastic Leukemia

Metastatic Breast Cancer

Top Venues

British journal of cancer

Clinical pharmacology and therapeutics

Clinical cancer research : an official journal of the American Association for Cancer Research

Journal of gynecologic oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Rui Kitadai, Tatsunori Shimoi, Shu Yazaki, Hitomi Sumiyoshi Okuma, Mai Hoshino, Munehiro Ito, Ayumi Saito, Shosuke Kita, Yuki Kojima, Tadaaki Nishikawa, Kazuki Sudo, Emi Noguchi, Yasuhiro Fujiwara, Masayuki Yoshida, Kan Yonemori
Clinicopathological and prognostic features of HER2-null and HER2-low advanced breast cancer treated with eribulin or capecitabine. Breast cancer (Tokyo, Japan) (2024)
Hitomi Sumiyoshi Okuma, Keisuke Watanabe, Kenji Tsuchihashi, Ryunosuke Machida, Ryo Sadachi, Akihiro Hirakawa, Hiroshi Ariyama, Masashi Kanai, Masahisa Kamikura, Kenta Anjo, Akari Hiramitsu, Shigeki Sekine, Natsuko Okita, Hiroyuki Mano, Hiroyoshi Nishikawa, Kenichi Nakamura, Kan Yonemori
Phase 2 trial of nivolumab in metastatic rare cancer with dMMR or MSI-H and relation with immune phenotypic analysis (the ROCK trial). Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Takafumi Koyama, Toshio Shimizu, Yuki Kojima, Kazuki Sudo, Hitomi Sumiyoshi Okuma, Tatsunori Shimoi, Hitotshi Ichikawa, Shinji Kohsaka, Ryo Sadachi, Akihiro Hirakawa, Akihiko Yoshida, Reiko Makihara Ando, Toshihide Ueno, Mitsuru Yanagaki, Naoko Matsui, Kenichi Nakamura, Noboru Yamamoto, Kan Yonemori
Clinical activity and exploratory resistance mechanism of milademetan, an MDM2 inhibitor, in intimal sarcoma with MDM2 amplification: an open-label phase 1b/2 study. Cancer discovery (2023)
Hitomi Sumiyoshi Okuma, Hiroshi Yoshida, Yoshihisa Kobayashi, Motoko Arakaki, Chiharu Mizoguchi, Lina Inagaki, Voon Pei Jye, Adam Malik Bin Ismail, Hwoei Fen Soo Hoo, Suhana Yusak, Marcelo Severino B Imasa, Thinh Nguyen Huy, Tu Thai Anh, Shinji Kohsaka, Hiroyuki Mano, Kan Yonemori, Kenichi Nakamura, Yasushi Yatabe
Molecular pathology quality control in Southeast Asia: Results of a Multiregional Quality Assurance Study from MASTER KEY Asia. Cancer science (2023)
Shu Yazaki, Roberto Salgado, Tatsunori Shimoi, Masayuki Yoshida, Sho Shiino, Tomoya Kaneda, Yuki Kojima, Hitomi Sumiyoshi Okuma, Tadaaki Nishikawa, Kazuki Sudo, Emi Noguchi, Takeshi Murata, Shin Takayama, Akihiko Suto, Yuichiro Ohe, Kan Yonemori
Impact of adjuvant chemotherapy and radiotherapy on tumour-infiltrating lymphocytes and PD-L1 expression in metastatic breast cancer. British journal of cancer 128 (4) (2022)
Shu Yazaki, Roberto Salgado, Tatsunori Shimoi, Masayuki Yoshida, Sho Shiino, Tomoya Kaneda, Yuki Kojima, Hitomi Sumiyoshi Okuma, Tadaaki Nishikawa, Kazuki Sudo, Emi Noguchi, Takeshi Murata, Shin Takayama, Akihiko Suto, Yuichiro Ohe, Kan Yonemori
Impact of adjuvant chemotherapy and radiotherapy on tumour-infiltrating lymphocytes and PD-L1 expression in metastatic breast cancer. British journal of cancer 128 (4) (2022)
Masayuki Okumura, Junyan Du, Shun-Ichiro Kageyama, Riu Yamashita, Yumi Hakozaki, Atsushi Motegi, Hidehiro Hojo, Masaki Nakamura, Yasuhiro Hirano, Yusuke Okuma, Hitomi Sumiyoshi Okuma, Katsuya Tsuchihara, Tetsuo Akimoto
Comprehensive screening for drugs that modify radiation-induced immune responses. British journal of cancer 126 (12) (2022)
Shu Yazaki, Roberto Salgado, Tatsunori Shimoi, Masayuki Yoshida, Sho Shiino, Tomoya Kaneda, Yuki Kojima, Hitomi Sumiyoshi Okuma, Tadaaki Nishikawa, Kazuki Sudo, Emi Noguchi, Takeshi Murata, Shin Takayama, Akihiko Suto, Yuichiro Ohe, Kan Yonemori
Impact of adjuvant chemotherapy and radiotherapy on tumour-infiltrating lymphocytes and PD-L1 expression in metastatic breast cancer. British journal of cancer (2022)
Shu Yazaki, Roberto Salgado, Tatsunori Shimoi, Masayuki Yoshida, Sho Shiino, Tomoya Kaneda, Yuki Kojima, Hitomi Sumiyoshi Okuma, Tadaaki Nishikawa, Kazuki Sudo, Emi Noguchi, Takeshi Murata, Shin Takayama, Akihiko Suto, Yuichiro Ohe, Kan Yonemori
Impact of adjuvant chemotherapy and radiotherapy on tumour-infiltrating lymphocytes and PD-L1 expression in metastatic breast cancer. British journal of cancer (2022)
Shu Yazaki, Roberto Salgado, Tatsunori Shimoi, Masayuki Yoshida, Sho Shiino, Tomoya Kaneda, Yuki Kojima, Hitomi Sumiyoshi Okuma, Tadaaki Nishikawa, Kazuki Sudo, Emi Noguchi, Takeshi Murata, Shin Takayama, Akihiko Suto, Yuichiro Ohe, Kan Yonemori
Impact of adjuvant chemotherapy and radiotherapy on tumour-infiltrating lymphocytes and PD-L1 expression in metastatic breast cancer. British journal of cancer (2022)
Shu Yazaki, Yuki Kojima, Hiroshi Yoshida, Shigemasa Takamizawa, Rui Kitadai, Tadaaki Nishikawa, Tatsunori Shimoi, Kazuki Sudo, Ayumi Saito, Hitomi Sumiyoshi Okuma, Maki Tanioka, Emi Noguchi, Masaya Uno, Mitsuya Ishikawa, Tomoyasu Kato, Yasuhiro Fujiwara, Yuichiro Ohe, Kan Yonemori
High expression of folate receptor alpha is associated with poor prognosis in patients with cervical cancer. Journal of gynecologic oncology 33 (6) (2022)
Shu Yazaki, Roberto Salgado, Tatsunori Shimoi, Masayuki Yoshida, Sho Shiino, Tomoya Kaneda, Yuki Kojima, Hitomi Sumiyoshi Okuma, Tadaaki Nishikawa, Kazuki Sudo, Emi Noguchi, Takeshi Murata, Shin Takayama, Akihiko Suto, Yuichiro Ohe, Kan Yonemori
Impact of adjuvant chemotherapy and radiotherapy on tumour-infiltrating lymphocytes and PD-L1 expression in metastatic breast cancer. British journal of cancer 128 (4) (2022)
Shu Yazaki, Roberto Salgado, Tatsunori Shimoi, Masayuki Yoshida, Sho Shiino, Tomoya Kaneda, Yuki Kojima, Hitomi Sumiyoshi Okuma, Tadaaki Nishikawa, Kazuki Sudo, Emi Noguchi, Takeshi Murata, Shin Takayama, Akihiko Suto, Yuichiro Ohe, Kan Yonemori
Impact of adjuvant chemotherapy and radiotherapy on tumour-infiltrating lymphocytes and PD-L1 expression in metastatic breast cancer. British journal of cancer 128 (4) (2022)
Hitomi Sumiyoshi Okuma, Kan Yonemori, Shoko N Narita, Tamie Sukigara, Akihiro Hirakawa, Toshio Shimizu, Taro Shibata, Akira Kawai, Noboru Yamamoto, Kenichi Nakamura, Toshiro Nishida, Yasuhiro Fujiwara
MASTER KEY Project: Powering Clinical Development for Rare Cancers Through a Platform Trial. Clinical pharmacology and therapeutics 108 (3) (2020)